Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
- PMID: 34717804
- PMCID: PMC8550921
- DOI: 10.1016/S1473-3099(21)00646-0
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
Conflict of interest statement
We declare no competing interests.
Comment in
-
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination - Authors' reply.Lancet Infect Dis. 2021 Nov;21(11):1492-1493. doi: 10.1016/S1473-3099(21)00631-9. Lancet Infect Dis. 2021. PMID: 34717806 Free PMC article. No abstract available.
Comment on
-
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.Lancet Infect Dis. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5. Epub 2021 Aug 16. Lancet Infect Dis. 2022. PMID: 34411532 Free PMC article.
-
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.Lancet Infect Dis. 2021 Nov;21(11):1491-1492. doi: 10.1016/S1473-3099(21)00621-6. Lancet Infect Dis. 2021. PMID: 34717805 Free PMC article. No abstract available.
References
-
- Klungel OH, Pottegård A. Strengthening international surveillance of vaccine safety. BMJ. 2021;374 - PubMed
-
- Raschi E, Moretti U, Salvo F, et al. Evolving roles of spontaneous reporting systems to assess and monitor drug safety. Pharmacovigilance. 2018 doi: 10.5772/intechopen.79986. published online Nov 5. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical